People with type 2 diabetes and obesity who develop kidney disease may benefit more from bariatric surgery than from GLP-1 ...
To date, a number of clinical trials have shown weight regain after discontinuing GLP-1 drugs. In the STEP 1 trial extension, ...
According to health experts, if you eat the right foods, your body will trigger the natural release of GLP-1 – which is what ...
The arrival of GLP-1 analog drugs (such as Wegovy) marked a huge shift in the weight-loss drug market. These drugs have been ...
BOSTON - There is concern over the newest weight loss drugs sparking eating disorders in teens. Newer GLP-1 weight loss drugs ...
At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...
A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Ongoing shortages of popular weight loss and diabetes drugs in the U.S. have spurred fierce competition between established ...
Results of the human clinical trial will be shared with LifeVantage Consultants at Market Connect in Kansas City, October ...
An emerging market for compounded weight loss injections that mimic brand-name drugs such as Ozempic, Wegovy, Mounjaro and ...
The Gavin and Stacey star has come to the realisation that ‘nothing about my eating has anything to do with being hungry’ ...